Cargando…
Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model
The use of chemotherapeutic agents is of paramount importance when treating colorectal cancer (CRC). Unfortunately, one of the most frequent chemotherapy (CTx) side effects is intestinal mucositis (IM), which may present with several clinical symptoms such as nausea, bloating, vomiting, pain, and di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005486/ https://www.ncbi.nlm.nih.gov/pubmed/36904117 http://dx.doi.org/10.3390/nu15051117 |
_version_ | 1784905092917362688 |
---|---|
author | Jakubauskas, Matas Jakubauskiene, Lina Leber, Bettina Horvath, Angela Strupas, Kestutis Stiegler, Philipp Schemmer, Peter |
author_facet | Jakubauskas, Matas Jakubauskiene, Lina Leber, Bettina Horvath, Angela Strupas, Kestutis Stiegler, Philipp Schemmer, Peter |
author_sort | Jakubauskas, Matas |
collection | PubMed |
description | The use of chemotherapeutic agents is of paramount importance when treating colorectal cancer (CRC). Unfortunately, one of the most frequent chemotherapy (CTx) side effects is intestinal mucositis (IM), which may present with several clinical symptoms such as nausea, bloating, vomiting, pain, and diarrhea and even can result in life-threatening complications. There is a focused scientific effort towards developing new therapies to prevent and treat IM. The aim of this study was to assess the outcomes of probiotic supplementation on CTx-induced IM in a CRC liver metastasis rat model. Six-week-old male Wistar rats received either a multispecies probiotic or placebo mixture. On the 28th experiment day, rats received FOLFOX CTx, and afterwards, the severity of diarrhea was evaluated twice daily. Stool samples were collected for further microbiome analysis. Additionally, immunohistochemical stainings of ileum and colon samples with were performed with MPO, Ki67, and Caspase-3 antibodies. Probiotic supplementation alleviates the severity and length of CTx-induced diarrhea. Additionally, probiotics significantly reduced FOLFOX-induced weight and blood albumin loss. Furthermore, probiotic supplementation mitigated CTx-induced histological changes in the gut and promoted intestinal cell regeneration. This study shows that multispecies probiotic supplementation attenuates FOLFOX-induced IM symptoms by inhibiting apoptosis and promoting intestinal cell proliferation. |
format | Online Article Text |
id | pubmed-10005486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100054862023-03-11 Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model Jakubauskas, Matas Jakubauskiene, Lina Leber, Bettina Horvath, Angela Strupas, Kestutis Stiegler, Philipp Schemmer, Peter Nutrients Article The use of chemotherapeutic agents is of paramount importance when treating colorectal cancer (CRC). Unfortunately, one of the most frequent chemotherapy (CTx) side effects is intestinal mucositis (IM), which may present with several clinical symptoms such as nausea, bloating, vomiting, pain, and diarrhea and even can result in life-threatening complications. There is a focused scientific effort towards developing new therapies to prevent and treat IM. The aim of this study was to assess the outcomes of probiotic supplementation on CTx-induced IM in a CRC liver metastasis rat model. Six-week-old male Wistar rats received either a multispecies probiotic or placebo mixture. On the 28th experiment day, rats received FOLFOX CTx, and afterwards, the severity of diarrhea was evaluated twice daily. Stool samples were collected for further microbiome analysis. Additionally, immunohistochemical stainings of ileum and colon samples with were performed with MPO, Ki67, and Caspase-3 antibodies. Probiotic supplementation alleviates the severity and length of CTx-induced diarrhea. Additionally, probiotics significantly reduced FOLFOX-induced weight and blood albumin loss. Furthermore, probiotic supplementation mitigated CTx-induced histological changes in the gut and promoted intestinal cell regeneration. This study shows that multispecies probiotic supplementation attenuates FOLFOX-induced IM symptoms by inhibiting apoptosis and promoting intestinal cell proliferation. MDPI 2023-02-23 /pmc/articles/PMC10005486/ /pubmed/36904117 http://dx.doi.org/10.3390/nu15051117 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jakubauskas, Matas Jakubauskiene, Lina Leber, Bettina Horvath, Angela Strupas, Kestutis Stiegler, Philipp Schemmer, Peter Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title | Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title_full | Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title_fullStr | Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title_full_unstemmed | Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title_short | Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model |
title_sort | probiotic supplementation attenuates chemotherapy-induced intestinal mucositis in an experimental colorectal cancer liver metastasis rat model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005486/ https://www.ncbi.nlm.nih.gov/pubmed/36904117 http://dx.doi.org/10.3390/nu15051117 |
work_keys_str_mv | AT jakubauskasmatas probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT jakubauskienelina probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT leberbettina probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT horvathangela probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT strupaskestutis probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT stieglerphilipp probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel AT schemmerpeter probioticsupplementationattenuateschemotherapyinducedintestinalmucositisinanexperimentalcolorectalcancerlivermetastasisratmodel |